India-based Twilight Litaka Pharma has entered into an agreement with South Africa-based Interpro Healthcare to supply technical know-how, on 13 October 2010.
Subscribe to our email newsletter
Twilight will offer technical know-how against 26% of fully paid equity shares of Interpro Healthcare, the company said in a filing to the Bombay Stock Exchange.
Interpro will be required to buy the products exclusively from Twilight which will be registered and marketed by Interpro Healthcare in South Africa.
The deal is expected to enable Twilight to foray into the South African pharma market.
Twilight manufactures drugs and formulations related to analgesics, antibiotics, anti-bacterials, vitamins and cardialogy in the form of tablets, capsules, ointment and liquids.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.